Celltex News
ChinaXiv Reports Clinical Remission of a Critically Ill COVID-19 Patient Treated by Human Umbilical Cord Mesenchymal Stem Cells
The COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies.
ChinaXiv has performed a recent study that has proven significant improvement of a critically ill COVID-19 patient that was treated with the transfer of human umbilical cord mesenchymal stem cells. Celltex is continuing to monitor and participate in this effective research.
If you currently have your MSCs banked at Celltex and are wondering what options are available to you, please contact the Client Services team today by completing the form on our Request a Consultation page, by calling (713) 590-1000 or sending an email to info@celltexbank.com. If you are not a client but would like to bank your MSCs, please complete our online client assessment and a Client Services Coordinator will contact you.
More Recent News
Stem Cell Therapy: How Are MSCs Administered to the Body?
Through the years, several stem cell therapy delivery methods have emerged. This article explores some of the most common routes of administration physicians may recommend today.
Read MoreThe Bryan-College Station Eagle: Celltex’s Jackie Sherrill Featured as a Guest Columnist to Comment on the Upcoming Texas A&M vs. Texas Game
Coach Jackie Sherrill, President of Celltex Sports Biologics, was featured as a guest columnist in The Bryan-College Station Eagle to share his excitement for the renewed rivalry game between Texas A&M University and the University of Texas.
During Sherrill’s tenure as Texas A&M’s head football coach from 1982 to 1988, the team went 5-2 against Texas. In the article, Coach Sherrill reflects on the past rivalry games and shares what he believes to be the key to winning this year’s Lone Star Showdown.
Read More